Sahajanand Medical Technologies promotes Anil Suri to Chief Commercial Officer

Suri has been with SMT for the past three years, during which he has played a key role in building a high-performing team, fostering a culture of trust and collaboration

Sahajanand Medical Technologies (SMT) has promoted Anil Suri to the position of Chief Commercial Officer (CCO).

The appointment comes at a time when the medical technology company looks to strengthen its commercial strategy and accelerate sustainable growth across domestic and international markets.

Suri has been with SMT for the past three years, during which he has played a key role in building a high-performing team, fostering a culture of trust and collaboration, and driving growth across the company’s Asia-Pacific (APAC) business.

In his new role, Suri will be responsible for leading SMT’s commercial strategy, advancing commercial excellence and strengthening alignment across the company’s domestic and international markets.

With more than two decades of experience spanning India, Southeast Asia, the broader APAC region and the United States, Suri brings extensive market knowledge and commercial experience to the position.

His focus will include strengthening customer-centric growth and supporting SMT’s expansion across global markets.